Stay updated on BI 695501 vs Adalimumab in Active RA Clinical Trial
Sign up to get notified when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.

Latest updates to the BI 695501 vs Adalimumab in Active RA Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page shows an updated site revision to v3.4.2, and the prior funding-status notice (v3.4.1) has been removed.SummaryDifference0.2%

- Check21 days agoChange DetectedA government funding notice about potential delays and NIH operations has been added to the page, and the revision shows v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a glossary toggle (Show glossary). Updated QC-related labels for capitalization and introduced a new site version tag 'Revision: v3.4.0'.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision v3.3.4 was added and revision v3.3.3 was removed. This is a minor housekeeping update to the page's revision history.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a comprehensive Locations section listing trial sites by state (e.g., AL, AZ, CA, CO, FL, etc.). Updated revision to v3.3.3 and removed v3.3.2/HHS Vulnerability Disclosure.SummaryDifference1%

- Check92 days agoChange DetectedAdded note that publications are automatically filled from PubMed and may not be about the study, and updated the revision to v3.3.2. Removed the older statement that publications come from PubMed and are automatically created by ClinicalTrials.gov Identifier (NCT Number); to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to BI 695501 vs Adalimumab in Active RA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 695501 vs Adalimumab in Active RA Clinical Trial page.